Masimo Corporation (MASI)
USD 153.68
(1.45%)
USD 153.68
(1.45%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 804 Million USD | 4.08% |
| 2022 | 772.5 Million USD | 208.41% |
| 2021 | -712.58 Million USD | -17.38% |
| 2020 | -607.09 Million USD | -10.95% |
| 2019 | -547.2 Million USD | 0.96% |
| 2018 | -552.49 Million USD | -75.23% |
| 2017 | -315.3 Million USD | -3.07% |
| 2016 | -305.89 Million USD | -679.05% |
| 2015 | 52.82 Million USD | 721.29% |
| 2014 | -8.5 Million USD | 91.06% |
| 2013 | -95.13 Million USD | -36.95% |
| 2012 | -69.46 Million USD | 46.47% |
| 2011 | -129.76 Million USD | -47.23% |
| 2010 | -88.13 Million USD | 33.14% |
| 2009 | -131.82 Million USD | 9.89% |
| 2008 | -146.28 Million USD | -122.69% |
| 2007 | -65.69 Million USD | -91.3% |
| 2006 | -34.34 Million USD | -330.66% |
| 2005 | 14.88 Million USD | 0.0% |
| 2003 | -11.12 Million USD | -42.76% |
| 2002 | -7.79 Million USD | 0.0% |
| 1999 | -12.1 Million USD | -19.8% |
| 1998 | -10.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 731 Million USD | -9.45% |
| 2024 Q1 | 807.3 Million USD | 0.41% |
| 2024 Q3 | 574.7 Million USD | -3.91% |
| 2023 Q4 | 804 Million USD | 2.33% |
| 2023 Q2 | 738.1 Million USD | 2.03% |
| 2023 Q3 | 785.7 Million USD | 6.45% |
| 2023 Q1 | 723.4 Million USD | -12.41% |
| 2023 FY | 804 Million USD | 4.08% |
| 2022 Q1 | -681.2 Million USD | 4.4% |
| 2022 Q2 | 734.7 Million USD | 207.85% |
| 2022 Q3 | 764.2 Million USD | 4.02% |
| 2022 Q4 | 825.9 Million USD | 8.07% |
| 2022 FY | 772.5 Million USD | 208.41% |
| 2021 Q1 | -516.5 Million USD | 14.92% |
| 2021 Q4 | -712.58 Million USD | -15.17% |
| 2021 Q3 | -618.73 Million USD | -14.42% |
| 2021 FY | -712.58 Million USD | -17.38% |
| 2021 Q2 | -540.76 Million USD | -4.7% |
| 2020 Q2 | -604.72 Million USD | -4.52% |
| 2020 Q1 | -578.59 Million USD | -5.74% |
| 2020 FY | -607.09 Million USD | -10.95% |
| 2020 Q4 | -607.09 Million USD | 5.21% |
| 2020 Q3 | -640.49 Million USD | -5.92% |
| 2019 FY | -547.2 Million USD | 0.96% |
| 2019 Q1 | -391.44 Million USD | 29.15% |
| 2019 Q4 | -547.2 Million USD | -11.17% |
| 2019 Q3 | -492.22 Million USD | -26.93% |
| 2019 Q2 | -387.79 Million USD | 0.93% |
| 2018 Q4 | -552.49 Million USD | -11.96% |
| 2018 Q3 | -493.48 Million USD | -14.86% |
| 2018 FY | -552.49 Million USD | -75.23% |
| 2018 Q1 | -369.49 Million USD | -17.19% |
| 2018 Q2 | -429.64 Million USD | -16.28% |
| 2017 Q1 | -343.82 Million USD | -12.4% |
| 2017 Q4 | -315.3 Million USD | -8.75% |
| 2017 Q3 | -289.94 Million USD | 12.52% |
| 2017 FY | -315.3 Million USD | -3.07% |
| 2017 Q2 | -331.44 Million USD | 3.6% |
| 2016 Q2 | 59.02 Million USD | -30.71% |
| 2016 FY | -305.89 Million USD | -679.05% |
| 2016 Q4 | -305.89 Million USD | -1253.81% |
| 2016 Q3 | 26.51 Million USD | -55.08% |
| 2016 Q1 | 85.17 Million USD | 61.24% |
| 2015 Q4 | 52.82 Million USD | -39.0% |
| 2015 FY | 52.82 Million USD | 721.29% |
| 2015 Q1 | -10.52 Million USD | -23.82% |
| 2015 Q2 | 58.28 Million USD | 653.64% |
| 2015 Q3 | 86.59 Million USD | 48.57% |
| 2014 Q2 | -21.85 Million USD | 81.37% |
| 2014 Q1 | -117.27 Million USD | -23.27% |
| 2014 FY | -8.5 Million USD | 91.06% |
| 2014 Q4 | -8.5 Million USD | -236.2% |
| 2014 Q3 | 6.24 Million USD | 128.57% |
| 2013 Q1 | -81.22 Million USD | -16.93% |
| 2013 FY | -95.13 Million USD | -36.95% |
| 2013 Q4 | -95.13 Million USD | -4.12% |
| 2013 Q3 | -91.36 Million USD | -17.53% |
| 2013 Q2 | -77.73 Million USD | 4.3% |
| 2012 Q1 | -128.73 Million USD | 0.79% |
| 2012 Q4 | -69.46 Million USD | 38.45% |
| 2012 Q3 | -112.85 Million USD | 7.05% |
| 2012 Q2 | -121.42 Million USD | 5.68% |
| 2012 FY | -69.46 Million USD | 46.47% |
| 2011 FY | -129.76 Million USD | -47.23% |
| 2011 Q1 | -105.44 Million USD | -19.65% |
| 2011 Q2 | -125.54 Million USD | -19.06% |
| 2011 Q3 | -143.05 Million USD | -13.95% |
| 2011 Q4 | -129.76 Million USD | 9.29% |
| 2010 Q4 | -88.13 Million USD | 29.62% |
| 2010 FY | -88.13 Million USD | 33.14% |
| 2010 Q3 | -125.21 Million USD | -13.05% |
| 2010 Q1 | -35.93 Million USD | 72.74% |
| 2010 Q2 | -110.76 Million USD | -208.23% |
| 2009 FY | -131.82 Million USD | 9.89% |
| 2009 Q1 | -151.7 Million USD | -3.7% |
| 2009 Q4 | -131.82 Million USD | 24.36% |
| 2009 Q3 | -174.27 Million USD | -11.61% |
| 2009 Q2 | -156.14 Million USD | -2.92% |
| 2008 FY | -146.28 Million USD | -122.69% |
| 2008 Q2 | -101.97 Million USD | -20.09% |
| 2008 Q1 | -84.91 Million USD | -29.26% |
| 2008 Q4 | -146.28 Million USD | -20.05% |
| 2008 Q3 | -121.85 Million USD | -19.5% |
| 2007 Q3 | -54.48 Million USD | -2775.88% |
| 2007 Q1 | 8.82 Million USD | 125.71% |
| 2007 Q2 | 2.03 Million USD | -76.94% |
| 2007 Q4 | -65.69 Million USD | -20.58% |
| 2007 FY | -65.69 Million USD | -91.3% |
| 2006 Q4 | -34.34 Million USD | 0.0% |
| 2006 FY | -34.34 Million USD | -330.66% |
| 2005 Q4 | 14.88 Million USD | 0.0% |
| 2005 FY | 14.88 Million USD | 0.0% |
| 2003 FY | -11.12 Million USD | -42.76% |
| 2002 FY | -7.79 Million USD | 0.0% |
| 1999 FY | -12.1 Million USD | -19.8% |
| 1998 FY | -10.1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -31050.717% |
| AngioDynamics, Inc. | -70.14 Million USD | 1246.246% |
| AtriCure, Inc. | -9.81 Million USD | 8290.709% |
| Avinger, Inc. | 10.12 Million USD | -7844.664% |
| Azenta, Inc. | -618.47 Million USD | 229.997% |
| BioLife Solutions, Inc. | 7.25 Million USD | -10985.068% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 67.162% |
| Daxor Corporation | 755.65 Thousand USD | -106297.198% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 54793.878% |
| Femasys Inc. | -15.01 Million USD | 5454.576% |
| GlucoTrack, Inc. | -4.29 Million USD | 18815.084% |
| Harvard Bioscience, Inc. | 38.49 Million USD | -1988.854% |
| Hologic, Inc. | 374.4 Million USD | -114.744% |
| ICU Medical, Inc. | 1.45 Billion USD | 44.571% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 130.222% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 11525.128% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 15639.235% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 18852.418% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 18852.418% |
| Microbot Medical Inc. | -2.28 Million USD | 35270.604% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 8478.715% |
| Merit Medical Systems, Inc. | 302.22 Million USD | -166.029% |
| Nephros, Inc. | -2.47 Million USD | 32637.434% |
| NovoCure Limited | 355.42 Million USD | -126.211% |
| NEXGEL, Inc. | 98 Thousand USD | -820308.163% |
| NEXGEL, Inc. | 98 Thousand USD | -820308.163% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | -1261.443% |
| OraSure Technologies, Inc. | -276.9 Million USD | 390.354% |
| Pro-Dex, Inc. | 10.91 Million USD | -7265.335% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 2382.729% |
| Predictive Oncology Inc. | -5.87 Million USD | 13792.457% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -26441.81% |
| QuidelOrtho Corporation | 2.49 Billion USD | 67.778% |
| Repligen Corporation | -39.51 Million USD | 2134.464% |
| Sanara MedTech Inc. | 6.64 Million USD | -11999.516% |
| STAAR Surgical Company | -147.2 Million USD | 646.181% |
| Sharps Technology, Inc. | -3.01 Million USD | 26785.183% |
| Utah Medical Products, Inc. | -92.52 Million USD | 968.945% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 59.084% |
| Jin Medical International Ltd. | -2.81 Million USD | 28645.987% |